Strategies in the control of asthma.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000485:Allergens / Q000008:administration & dosage; D001249:Asthma / Q000188:drug therapy / Q000209:etiology / Q000628:therapy*; D001250:Asthma, Exercise-Induced / Q000175:diagnosis; D001993:Bronchodilator Agents / Q000009:adverse effects / Q000627:therapeutic use; D002675:Child, Preschool; D004205:Cromolyn Sodium / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005764:Gastroesophageal Reflux / Q000150:complications; D006801:Humans; D007223:Infant; D009784:Occupational Diseases / Q000139:chemically induced; D010349:Patient Compliance; D011058:Pollen; D012907:Smoking; D013172:Spores, Fungal; D013806:Theophylline / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000485:Allergens; D001993:Bronchodilator Agents; D013806:Theophylline; D004205:Cromolyn Sodium